Cure8 research brief
Why This Matters
Sleep disturbance is common in IBD and relates to disease activity, stress, anxiety, and circadian timing. There is high patient interest in sleep-focused testing and nonpharmacologic therapies but very low use of evidence-based treatments like CBT-I, indicating a gap in care.
Who Should Pay Attention
Adults with Crohn's disease or ulcerative colitis; gastroenterologists and IBD care teams; sleep clinicians and behavioral therapists; researchers of sleep, circadian biology, and IBD outcomes.
Study Snapshot
What To Know
This cross-sectional survey of 204 adults with Crohn’s disease or ulcerative colitis found 76.5% reported poor sleep quality and 55.9% had clinically significant sleep disturbance.
Active disease, higher perceived stress, and anxiety were associated with greater odds of clinically significant sleep disturbance; morning or intermediate chronotype was associated with lower odds compared with evening chronotype.
Many participants described self-management for sleep (sleep hygiene, OTC remedies) and high interest in wearable monitoring, home-based testing, behavioral therapies, and light therapy, but very low prior use of CBT-I (0.5%).
The authors conclude sleep disturbance in IBD likely reflects interacting inflammatory, psychological, and circadian factors and that evidence-based therapies are underused.
Keep In Mind
Cross-sectional survey design limits causal inference. Findings are based on self-reported measures and an abstract-level article; interpret associations accordingly.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.